Blume Capital Management, Inc. Gsk PLC Transaction History

Blume Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$42.05 - $47.77 $73,587 - $83,597	-1,750 Reduced 59.32%	1,200 $52,000
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $8,045 - $9,548	200 Added 7.27%	2,950 $129,000
Q4 2021 Feb 07, 2022	BUY	$38.88 - $45.31 $28,926 - $33,710	744 Added 37.09%	2,750 $121,000
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $77,812 - $86,578	2,006 New	2,006 $77,000
Q2 2019 Jul 29, 2019	SELL	$39.4 - $42.7 $4,452 - $4,825	-113 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$39.75 - $42.69 $1.91 Million - $2.05 Million	-47,980 Reduced 99.77%	113 $5,000
Q2 2018 Aug 02, 2018	SELL	$39.61 - $42.76 $20,795 - $22,449	-525 Reduced 1.08%	48,093 $1.94 Million
Q1 2018 May 04, 2018	BUY	$36.18 - $40.15 $1.75 Million - $1.94 Million	48,335 Added 17079.51%	48,618 $1.9 Million
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $11,161 - $11,758	283	283 $11,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Blume Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Blume Capital Management, Inc. with notifications on news.